Last reviewed · How we verify
Primary progressive multiple sclerosis
Approved treatments
- Ocrevus · Kessler Foundation
- Ocrevus · Roche
Ocrevus works by binding to the CD20 protein on B cells, marking them for destruction and reducing their ability to contribute to the disease process.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Primary progressive multiple sclerosis patent landscape — cliff calendar, originator estates, attackable patents
- Primary progressive multiple sclerosis treatment landscape brief
- Primary progressive multiple sclerosis treatment updates RSS
Frequently asked questions about Primary progressive multiple sclerosis
What drugs treat Primary progressive multiple sclerosis?
Tracked treatments include Ocrevus.
What is the treatment for Primary progressive multiple sclerosis?
Standard treatment for Primary progressive multiple sclerosis includes Ocrevus. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Primary progressive multiple sclerosis patent cliff · Primary progressive multiple sclerosis CI report
- Treatment: Ocrevus · Kessler Foundation
- Treatment: Ocrevus · Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing